Acumen Pharmaceuticals, Inc. (ABOS)
0.245
+0.02
(+9.62%)
USD |
NASDAQ |
Nov 09, 12:07
Acumen Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | -229.5% |
| September 30, 2020 | -341.1% |
| Date | Value |
|---|---|
| June 30, 2020 | -1.35K% |
| March 31, 2020 | -904.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 15.64% |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | -1.02% |
| Savara, Inc. | -- |
| Vericel Corp. | 16.59% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -151.6% |
| Return on Assets | -86.57% |
| Return on Invested Capital | -105.2% |
| Return on Net Operating Assets | -15.02K% |